Collegium Pharmaceutical (COLL) Files $86.25M Common IPO
Get Alerts COLL Hot Sheet
Join SI Premium – FREE
Collegium Pharmaceutical, Inc. (Nasdaq: COLL) filed a registration with the U.S. SEC for an IPO of its Commmon Stock. The proposed maximum offering amount is $86.25 million. The company plans to list on the Nasdaq: under the ticker, COLL.
Underwriters on the offering include Jefferies, Piper Jaffray, Wells Fargo Securities, and Needham & Company.
Collegium Pharmaceutical is a specialty pharmaceutical company developing and planning to commercialize next-generation abuse-deterrent products that incorporate our patented DETERx® platform technology for the treatment of chronic pain and other diseases.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- AZZ, Inc. (AZZ) Announces Proposed 4M Share Offering
- Siebert Financial Corp (SIEB) Receives Nasdaq Non-compliance Notice
- Genco Shipping & Trading Limited (GNK) Sends Letter to Shareholders
Create E-mail Alert Related Categories
IPOsRelated Entities
Piper Jaffray, Jefferies & Co, Needham & Company, Wells Fargo, IPOSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!